#118Extended selection 101–500
BioAge Labs
California
Peptides and metabolic medicines
Manufacturing profile
Peptides and metabolic medicines
Biopharma hub: California
Selection basis
The company is placed in positions 101–500 as a manufacturer, biotech, generics, advanced-therapy company or CDMO with practical relevance to the FUZKK utility catalog.
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Representative manufacturing and QC chain
- 1Peptide synthesis or recombinant upstream
- 2Chromatography and UF/DF
- 3HPLC/LC-MS and CE peptide mapping
- 4Sterile filtration and cartridge/vial filling
- 5Particles, sterility, endotoxin and cold-chain release
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.
Methodology